https://pittplusme.org/study/1688
Actinic Keratosis of the Face and/or Scalp Study
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Do you have at least 4, but no more than 12, non-pigmented (flesh-toned) actinic keratosis lesions (“sun spots”) on your face and/or scalp? You may be able to participate in a study that is testing a study drug cream to see how safe and effective it is when compared to a placebo cream. Participation will last 14-20 weeks and will involve up to 5 in-person visits. Compensation is provided.
IRB: SSU00111067
- Galderma - RD.06.SPR.112199 / 7004981, A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Assess the Efficacy and Safety of Methyl aminolevulinate hydrochloride (MAL) 16.8% cream (CD06809-41) versus vehicle cream in the treatment of thin and moderately thick, nonhyperkeratotic, non-pigmented actinic keratosis of the face and scalp when using daylight photodynamic therapy (DL-PDT) (Pro00038825)
AGE:
18 and up
DURATION:
14-20 weeks
VISITS:
At least 5
LOCATION:
Falk Medical Building - Oakland
COMPENSATION:
$125 per visit
SHARE STUDY
MEET THE RESEARCHER
Laura Ferris
Laura Korb Ferris, MD, PhD, is Professor of Dermatology at the University of Pittsburgh School of Medicine, and is also the Director of Clinical Trials for the Department of Dermatology. Dr. Ferris earned her doctorate in immunology from Johns Hopkins University and her medical degree from the University of Maryland.